NCT02038816 Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS) Status TERMINATED Phase PHASE2
NCT02038010 BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx Status COMPLETED Phase PHASE1
NCT02036554 Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients Status UNKNOWN Phase PHASE4
NCT02035124 Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel Status WITHDRAWN Phase PHASE2
NCT02032810 Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma Status COMPLETED Phase PHASE1
NCT02028364 Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women Status COMPLETED Phase PHASE2
NCT02027376 Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients Status COMPLETED Phase PHASE1
NCT02023905 Everolimus With and Without Temozolomide in Adult Low Grade Glioma Status TERMINATED Phase PHASE2
NCT02021162 Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase N/A
NCT02015208 Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT01994590 Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Status TERMINATED Phase PHASE2
NCT01990196 Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01976390 Comparing Everolimus and Sirolimus in Renal Transplant Recipients Status COMPLETED Phase NA
NCT01973660 PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer Status COMPLETED Phase PHASE2
NCT01973218 Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years. Status COMPLETED Phase PHASE3
NCT01973205 Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine Status COMPLETED Phase PHASE3